All News

Zolbetuximab plus the chemotherapy regimen mFOLFOX6 improved progression-free survival and overall survival in certain patients with unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

An expert writes about his experience as a sarcoma medical oncologist and how the field may progress with several therapies in the pipeline.

A 17-year survivor shares her experience of getting diagnosed with mesothelioma at 36, when people with this cancer are typically diagnosed at a much older age and given months to live.

As a cancer survivor, I can relate to the lyrics of the Beatles’ song, “Let it Be.”

Brandi Benson was thousands of miles away from home serving in the military when she received her cancer diagnosis. Today she advises others going through their own journey to not give up.

Tecvayli, which was recently approved for pretreated relapsed/refractory myeloma, is a “much more convenient” treatment option than CAR-T cell therapy, one expert said.

The first patient was enrolled in a phase 1 trial analyzing MTX110 in patients with recurrent glioblastoma, an aggressive type of brain cancer.

While most patients want to learn more about complementary therapies, like exercise and nutrition, before undergoing cancer treatment, barriers exist to both patients and clinicians, research found.

After being diagnosed with cancer 13 years ago, I began to wonder if my diet had anything to do with it — so I made some changes to eat better.

When patients are aware of cancer disparities, it can empower them to be proactive about their care to close the prognostic gap between races.

Being a creative, I learned to solve many of the problems that life threw my way. But being artistically gifted was worthless for dealing with the stark realities of my wife’s cancer.

From odor to diet concerns, a nurse practitioner answers common questions about colostomies and ileostomies from patients with cancer.

My family put off future plans because of my cancer, but now I’ve decided to take risks and do what we always hoped to accomplish.

The FDA approved Elahere for patients with pretreated, folate receptor alpha (FRα)-positive platinum-resistant gynecological cancers

Does lung cancer screening continue after a person is finished with treatment and moves in to the survivorship stage?

Patients with myelofibrosis should be open about their treatment goals with their providers, and potentially consider getting a second opinion or participating in a clinical trial, one expert says.

Identifying genetic mutations in lung cancer has allowed researchers to develop treatments that target specific biomarkers over the past 20 years, but more research is needed to further the space.

On a recent hiking trip, I first felt too hot with my homemade prostheses, but then self-conscious when I took them off.

CURE® surveyed its audience to see if they had people in their life cut off communication after a cancer diagnosis, sometimes known as “cancer ghosting.” Here’s what they had to say.  

Patients should describe their symptoms in detail and seek early care for suspected lung cancer, especially since the disease may resemble pneumonia and bronchitis on imaging tests.

Aphexda was well tolerated and helped the majority of patients collect enough cells to go to transplant, study results showed.

As a pancreatic cancer survivor, I realized how important it is to help others who are in the throes of their cancer experience.

After being diagnosed with sarcoma while deployed overseas, military veteran Brandi Benson realized the importance of speaking up about health complications.

I have many things to be thankful for regarding my ovarian cancer: from my recent CT scan results to an excellent oncology team.

From the singer of “Duran Duran” revealing his stage 4 cancer diagnosis — and missing the band’s induction to the Rock & Roll Hall of Fame because of it — to Barry Corbin’s oral cancer fears, here’s what’s happening in the oncology space this week.

Light exercises, which can be done at home, may be beneficial for patients with lung cancer.

Imjudo, Imfinzi and chemotherapy improved overall and progression-free survival in certain patients with non-small cell lung cancer.

The Food and Drug Administration approved Adcetris plus chemotherapy for pediatric patients with classical high-risk Hodgkin lymphoma.

I once again find myself in the cancer gray zone after being diagnosed with pulmonary lung disease — will this lead to another cancer diagnosis?